Application of medical products: mandatory requirements, supervision of their compliance

Background. Specific features of medical products (MPs), their active development and implementation in healthcare require post-market control and safe use.
Objective: to study the existing state regulation in the field of medical products, methods of state control, self-control in medical organisations for their use.
Material and methods. Regulatory legal acts of the Russian Federation defining mandatory requirements, control over the use of MPs were analyzed. Indicators of Federal Service for Surveillance in Healthcare (Roszdravnadzor) in this area were studied. A survey of medical professionals on the safe use of MPs was conducted, the answers of 343 respondents were evaluated.
Results. The analysis of regulatory legal acts shows that, unlike with medicines, biomedical cellular products, when it comes to MPs application requirements, methods of use are not sufficiently specified. State control over the circulation of MPs is generally structured and regulated. The main ways of modern state control are the introduction of a risk-oriented approach to conducting scheduled inspections since 2018, the introduction of a mechanism to control purchases of medical services and products. Typical violations identified by Roszdravnadzor in medical organisations are the use of unregistered or substandard MPs. Also, a frequent violation is a failure to report (or untimely communication) to Roszdravnadzor about undesirable reactions when using MPs. State regulator has developed and approved a mandatory procedure for internal control of quality and safety of medical practice, including control over the storage and use of MPs. At the same time, according to the results of the survey, managers are not sufficiently informed on where to take up-to-date information that the MPs need to be stopped using. Additionally, the survey confirmed that representatives of medical organizations administrations know less than doctors about poor quality MPs in the clinic. Another finding of the survey was that the frequency of unwanted reactions to the application of MPs is significant, but the amount of reporting to the regulator is insufficient. This situation increases the risk of harm to the life and health of patients. In addition, there is a significant frequency of incidents in the use of MPs, with very little reporting to Roszdravnadzor from medical organizations.
Conclusion. Further improvement of regulation in the field of MPs circulation at the post-registration stage, strengthening of control, primarily internal, over their safe and effective use are necessary.

1. Tsyb S.A. Creating innovative pharmaceutical and medical industry in Russia. Vestnik Roszdravnadzora. 2017; № 5: 9–13 (in Russ.).

2. Medical products market in Russia 2019. Available at: https://news.medreestr.ru/2019/12/20/rynok-mi-v-rf-2019/ (in Russ.) (accessed 25.08.2021).

3. Omelyanovsky V.V. The main differences between medical devices and pharmaceuticals and distinctive features of their research. Medical Technologies. Assessment and Choice. 2013; 2: 42–52 (in Russ.).

4. Grennan M., Town R.J. Regulating innovation with uncertain quality: information, risk, and access in medical devices. Am Econ Rev. 2020; 110 (1): 120–61. https://doi.org/10.1257/aer.20180946.

5. Federal Law of the Russian Federation No. 61-FZ of 12.04.2010 “On circulation of medicines”. Available at: https://base.garant.ru/12174909/ (in Russ.) (accessed 25.08.2021).

6. Federal Law of the Russian Federation No. 180-FZ of 23.06.2016 “On biomedical cell products”. Available at: https://base.garant.ru/71427992/ (in Russ.) (accessed 25.08.2021).

7. Federal Law of the Russian Federation No. 323-FZ of 21.11.2011 “On the basics of public health protection in the Russian Federation”. Available at: https://base.garant.ru/12191967/ (in Russ.) (accessed 25.08.2021).

8. Decree of the Government of the Russian Federation of 01.06.2021 No. 852 “On licensing of medical activities (with the exception of the specified activities carried out by medical organizations and other organizations included in the private healthcare system on the territory of the Skolkovo Innovation Center) and invalidation of certain acts of the government of the Russian Federation”. Available at: https://base.garant.ru/400846456/ (in Russ.) (accessed 25.08.2021).

9. Order of the Ministry of Health of the Russian Federation of 20.12.2012 No. 1181n “On approval of the procedure for appointing and prescribing medical products, as well as prescription forms for medical products and the procedure for registration of these forms, their accounting and storage”. Available at: https://www.garant.ru/products/ipo/prime/doc/70305718/ (in Russ.) (accessed 25.08.2021).

10. Order of the Ministry of Health of the Russian Federation of 19.20.2020 No. 1113n “On approval of the procedure for reporting by subjects of circulation of medical products about all cases of detection of side effects not specified in the instructions for use or the operating manual of a medical product, about adverse reactions during its use, about the features of interaction of medical products with each other, about facts and circumstances that pose a threat to the life and health of citizens and medical workers during the use and operation of medical products”. Available at: https://base.garant.ru/75011335/ (in Russ.) (accessed 25.08.2021).

11. Decree of the Government of the Russian Federation of 14.04.2011 No. 270 “On the procedure and standards for providing medical products, medicines and medical equipment to the internal troops of the Ministry of Internal Affairs of the Russian Federation”. Available at: https://base.garant.ru/12184858/ (in Russ.) (accessed 25.08.2021).

12. Order of the Ministry of Health of the Russian Federation of 28.11.2013 No. 876n “On approval of the Administrative Regulations of the Federal Service for Supervision in the field of healthcare for the provision of state services for licensing production and maintenance activities (except if maintenance is carried out to meet the own needs of a legal entity or individual entrepreneur) of medical equipment”. Available at: https://www.garant.ru/products/ipo/prime/doc/70583980/ (in Russ.) (accessed 25.08.2021).

13. Decree of the Government of the Russian Federation of 27.04.2018 No. 788-r “On the list of key performance indicators of control and supervisory activities of federal executive authorities”. Available at: https://www.garant.ru/products/ipo/prime/doc/71834360/ (in Russ.) (accessed 25.08.2021).

14. Order of the Federal Service for Supervision in the Field of Healthcare of 10.07.2020 No. 5974 “On approval of the Administrative Regulations of the Federal Service for Supervision in the field of healthcare for the implementation of state quality control and safety of medical activities”. Available at: https://www.garant.ru/products/ipo/prime/doc/74382381/ (in Russ.) (accessed 25.08.2021).

15. Decree of the Government of the Russian Federation of 29.06.2021 No. 1048 “On approval of the regulations on federal state control (supervision) of the quality and safety of medical activities”. Available at: https://base.garant.ru/401422536/ (in Russ.) (accessed 25.08.2021).

16. Federal Law of 26.12.2008 No. 294-FZ “On the protection of the rights of legal entities and individual entrepreneurs in state control (supervision) and municipal control”. Available at: https://base.garant.ru/12164247/ (in Russ.) (accessed 25.08.2021).

17. Decree of the Government of the Russian Federation of 30.06.2021 No. 1066 “On approval of the Regulations on federal state control (supervision) over the circulation of medical products”. Available at: https://base.garant.ru/401422556/ (in Russ.) (accessed 25.08.2021).

18. Report on the implementation of state control (supervision) in the field of public health protection and on the effectiveness of such control (supervision) in 2019. Available at: https://roszdravnadzor.gov.ru/about/plans/documents/66146 (in Russ.) (accessed 25.08.2021).

19. Order of the Ministry of Health of the Russian Federation of 31.07.2020 No. 785n “On approval of Requirements for the organization and conduct of internal quality control and safety of medical activities”. Available at: https://base.garant.ru/74710282/ (in Russ.) (accessed 25.08.2021).

20. Order of Roszdravnadzor of 16.07.2020 No. 6262 “On approval of the departmental program for the prevention of violations of mandatory requirements in the implementation of state quality control and safety of medical activities, federal state supervision in the field of circulation of medicines and state control over the circulation of medical products”. Available at: https://roszdravnadzor.gov.ru/reform/prevention/documents/67629 (in Russ.) (accessed 25.08.2021).

21. WHO Global surveillance and monitoring system for substandard and falsified medical products. 2017. Available at: https://www.who.int/medicines/regulation/ssffc/publications/GSMSreport_EN.pdf?ua=1 (accessed 25.08.2021).